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Epithelial-to-mesenchymal transition is a hallmark event in the metastatic cascade confer-
ring invasive ability to tumor cells. There are ongoing efforts to replicate the physiological
events occurring during mobilization of tumor cells in model systems. However, few
systems are able to capture these complex in vivo events. The embryonic chicken trans-
plantation model has emerged as a useful system to assess melanoma cells including
functions that are relevant to the metastatic process, namely invasion and plasticity. The
chicken embryo represents an accessible and economical 3-dimensional in vivo model
for investigating melanoma cell invasion as it exploits the ancestral relationship between
melanoma and its precursor neural crest cells. We describe a methodology that enables
the interrogation of melanoma cell motility within the developing avian embryo.This model
involves the injection of melanoma cells into the neural tube of chicken embryos. Melanoma
cells are labeled using fluorescent tracker dye,Vybrant DiO, then cultured as hanging drops
for 24 h to aggregate the cells. Groups of approximately 700 cells are placed into the neural
tube of chicken embryos prior to the onset of neural crest migration at the hindbrain level
(embryonic day 1.5) or trunk level (embryonic day 2.5). Chick embryos are reincubated and
analyzed after 48 h for the location of melanoma cells using fluorescent microscopy on
whole mounts and cross-sections of the embryos. Using this system, we compared the
in vivo invasive behavior of epithelial-like and mesenchymal-like melanoma cells. We report
that the developing embryonic microenvironment confers motile abilities to both types of
melanoma cells. Hence, the embryonic chicken transplantation model has the potential to
become a valuable tool for in vivo melanoma invasion studies. Importantly, it may provide
novel insights into and reveal previously unknown mediators of the metastatic steps of
invasion and dissemination in melanoma.
Keywords: embryonic chicken transplantation, melanoma, epithelial-to-mesenchymal transition, invasion, neural
crest cells
INTRODUCTION
Melanoma is a frequent malignant neoplasm, and metastasis of
melanoma is the main cause of death in these patients (1–3).
Metastasis is a complicated, multi-step process that is still poorly
understood. Model systems have been developed to recapitulate
cellular invasion, which is the early crucial step of the metastatic
cascade (4, 5). Transwell invasion assays using the reconstituted
Matrigel in Boyden chamber inserts have been utilized to study
melanoma cell invasion in vitro (6, 7). However, the lack of in vivo
microenvironmental factors may confound the results. Due to the
transient and rare nature of the invasive process, there is a paucity
of techniques for studying and visualizing motile melanoma cells
in vivo.
Here, we describe a model using transplantation of melanoma
cells into the neural tube of the embryonic chicken that is gaining
traction for melanoma tumor invasion studies in vivo. This model
was originally reported by Drews et al. for assessing melanoma
cell behavior in vivo (8) and has been subsequently used by sev-
eral other groups (9–13). It involves injecting melanoma cells
into a microenvironment that is populated with neural crest
cells that undergo an epithelial-to-mesenchymal transition (EMT)
to exit from the neural tube and undergo extensive migration,
to eventually populate a great diversity of areas in the embryo
(14, 15). The developing chicken has been used extensively as
a model to study developmental EMT and neural crest biology
since the neural crest cells give rise to a wide variety of cell
types including melanocytes, peripheral neurons and glia, secre-
tory cells of the medulla, and bone and cartilage cells in the head
(16–19).
Recently, this model has been adapted for studying cancer cell
invasion since cancer cells use molecular programs, which are
comparable to those utilized by migrating neural crest cells in
the embryo (16, 20). Indeed, the molecular mechanisms for tis-
sue interaction, penetration, and remodeling that are seen during
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EMT in melanoma appear to have much in common with those
seen with their ancestral cells undergoing similar processes in the
neural crest. For instance, over 50 percent of genes associated
with EMT and cell migration were induced in melanoma cells
following exposure to the neural crest microenvironment (21,
22). Furthermore, transplanted melanoma cells respond to cues
within the host embryonic microenvironment and subsequently
mimic many aspects of neural crest cell motility without forming
tumors (11, 22).
The key advantages of using this model are, first, the easy access
to the developing embryo to visualize in vivo tumor cell behav-
ior and its ability to respond to microenvironmental cues (23).
Second, to clarify which specific factors and signaling pathways in
embryonic development also participate in maintenance of tumor
cell plasticity. Third, the legal and ethical restrictions are lim-
ited with early developmental stages of the chick embryo before
hatching. Fourth, the transplants are not rejected (13). Finally,
the short time frame required from start of the experiment to
readout, it’s relative affordability and the lack of need for a spe-
cialized housing facility renders the chick embryo a suitable model
system.
We and others have used this model to investigate the role of
candidate genes in invasion in vivo by perturbing gene expres-
sion with morpholino or siRNA approach (10–12, 24). The
ease of integrating this model with intravital imaging techniques
and laser capture microdissection assisted gene profiling strategy
has enabled the examination of dynamic temporal and spatial
gene regulation exhibited by motile cells in vivo (22). Alterna-
tively, invasive behavior of other tumor cells that share ancestral
relationship with neural crest cells could be studied using this
method (25). Although the avian embryo offers many advantages,
it may be preferable to compare the results obtained in mam-
malian embryos, which are presumably more closely related to the
environment found in human embryos (26).
We have previously reported the classification of metastatic
human melanoma cell lines into epithelial- and mesenchymal-
like cells based on gene expression profiling and functional
assays (12). Herein, we have compared the behavior of epithelial-
and mesenchymal-like melanoma cells in vivo. LM-MEL-8 is an
epithelial-like cell line that lacks invasive ability in vitro, whereas
LM-MEL-3 is a mesenchymal-like melanoma cell line with high
invasive ability in vitro. Both cells were chosen for further study
following transplantation into the chick neural tube where invasive
ability was assessed in vivo. Although previous studies have trans-
planted melanoma cells at the head level of chick neural tube, we
primarily performed transplantation at the trunk level of the chick
embryos as the melanocyte progenitors arise predominantly from
neural crest cells at this location.
MATERIALS
REAGENTS
• Melanoma cell lines LM-MEL-3 and LM-MEL-8 were estab-
lished from resected melanoma metastases. All tissue donors
provided written informed consent for tissue collection and
research, which was covered by protocols approved by the
Austin Health Human Research Ethics Committee, Melbourne,
Australia (approval number H2012/04446). All cell lines were
matched with their donors by HLA-typing. Cells were cultured
in RF-10 media (RPMI1640 supplemented with 10% fetal calf
serum) as described previously (27).
• Adult normal human melanocytes (Lonza Australia).
• 1× Dulbecco’s phosphate buffered saline (DPBS) without
calcium and magnesium (Life Technologies).
• TrypLETM (Life Technologies).
• Vybrant labeling DiO dye (Life Technologies).
• Fertilized chicken embryos (Research Poultry Farm, Australia).
• 70% ethanol.
• Sterile phosphate buffered saline and 1% penicillin/streptomycin
(PBS-Pen/Strep).
• India ink (Pelikan Fount).
• Paraformaldehyde, 4% (wt/vol): add 30 ml of 1×DPBS to 10 ml
of 16% (wt/vol) paraformaldehye (ProSciTech).
• 30% sucrose solution in DPBS.
• Tissue-Tek OCT solution (Olympus).
• Liquid nitrogen.
• Fluorescent mounting media (Dako).
EQUIPMENT
• Egg incubator (Bell South).
• Dissection microscope.
• Fluorescent stereomicroscope with epi-illuminaton (SteREO
Lumar V12 Carl Zeiss).
• Forceps size 3 and size 5.
• Scissors.
• Microscissors.
• Syringe (5 cc with a 18G needle and 1 cc with a 27G needle).
• Thin-walled glass capillaries (Harvard apparatus GC150T)
pulled to generate a fine tip.
• Sharpened tungsten wire needles.
• Transparent tape.
• Sylgard petridish.
METHODS
The experimental design of the protocol is depicted in Figures 1
and 2.
Incubation of fertilized eggs:
1. Place fertilized chicken eggs at 38°C in a humidified incuba-
tor for 48 h to allow the embryos to reach the desired stage of
development (28).
2. Turn the eggs after 24 h to ensure that the yolk does not attach
to the eggshell.
Labeling and hanging drop culture of melanoma cells:
3. Cells can be pre-treated with siRNA or other factors prior to
culturing as a hanging drop (11–13).
4. Aspirate media and wash cell monolayer with 1× DPBS. Add
3 ml of TrypLETM to the flask and incubate at 37°C until cells
detach.
5. Add 3 ml of media to the flask and transfer cells into a 15 ml
conical tube. Centrifuge at 1800 rpm for 5 min.
6. Aspirate the media and suspend cells at a density of 1× 106 in
1 ml 1× DPBS.
7. Add 1µl of the Vybrant cell labeling DiO dye to the cell
suspension and mix well by pipetting.
Frontiers in Oncology | Molecular and Cellular Oncology February 2015 | Volume 5 | Article 36 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Jayachandran et al. Chicken embryo melanoma model
FIGURE 1 | Preparing egg for transplantation. (A,B) Create a window in the
eggshell and (C) inject with India ink to better visualize the embryo.
(D) Perform staging of the embryo by counting the number of somites.
(E) An E2.5, or HH stage 14 embryo, showing the location of the transplanted
melanoma cells in green. (F)Wholemount view of the cranial region of an
E1.5, or HH stage 8+ embryo. (G) Schematic of an E1.5/HH8+ embryo,
showing the location of transplanted melanoma cells in green. Arrows point
to somites.
8. Incubate cells with labeling solution at 37°C for 20 minutes.
The DiO label is a lipophilic tracer dye. After 20 min, add 10 ml
of RF-10 media.
9. Centrifuge the tubes at 1800 rpm for 5 min. Aspirate the super-
natant and resuspend cells in media. Repeat the wash procedure
two more times.
10. Resuspend cells in media at a density of 5× 104 cells per 25µl
media. Pipette four 25µl drops of resuspended cells on the lid
of a 35 mm culture petridish. Place the lid on the culture dish
filled with 2 ml media. Incubate cells at 37°C for 24 h under
standard cell culture conditions.
Preparation of eggs:
11. Rinse eggs with 70% ethanol and wipe clean. Do not turn
eggs over at this time, the embryo will be on the uppermost
side.
12. Mount the egg on the stage of a dissection microscope. Using a
5 cc syringe fitted with an 18 gauge needle, pierce a small hole
in the eggshell and withdraw 3 ml of albumin from the caudal
region of the egg.
13. Cut a circular hole in the eggshell with scissors to create a
window to enable visualization of the yolk (Figures 1A,B).
14. Using a 1 cc syringe fitted with a 27 gage needle, inject 10%
India ink in PBS-Pen/Strep below the blastodisc to enable better
visualization of the embryo (Figure 1C).
15. Count the somite pairs in the embryo to determine the embry-
onic stage (28). Stage HH 12-14 embryos are used for this
procedure (Figure 1D).
16. Make a small nick with a needle in the vitelline membrane over-
lying the most caudal end of the neural tube. Other procedures
use similar processes to prepare chick embryos for grafting
experiments (29–31).
Transplantation of melanoma cells into the neural tube:
17. Melanoma cells cultured as hanging drops form clusters
(Figure 2A). Disaggregate the large cell clusters with needles
into similar sized smaller clumps of approximately 500 to 1200
cells (Figure 2B). We use this method as single cells injected
into the neural tube often float out. The clumps can be vari-
able in size but they are malleable. The size of clump that can be
inserted into the neural tube is limited by the width of the neural
tube; therefore, the width of the clump is typically reproducible
following placement in the neural tube, with greater variability
seen in the length of the clump along the neural tube.
18. Aspirate a small clump of melanoma cells into the pulled glass
pipette (Figure 2C).
19. Transplant the melanoma cells into the lumen of the neural
tube in the trunk region, just caudal to the most caudal somites
(Figures 1E and 2E). The glass pipette can be guided into the
neural tube through the open neuropore, and cells injected into
the neural tube caudal to the last somite (Figure 2E). Alterna-
tively, a clump of cells can be maneuvered into the neural tube
using tungsten wire needles through the open neuropore or a
slit cut carefully into the dorsal neural tube closer to the most
caudal somite. This is a delicate process with variable success
rate. It is useful to incubate approximately 2 dozen eggs to
generate roughly 6–12 injected embryos.
20. For transplantation into the cranial region, eggs are incubated
for 1.5 days prior to injection, and embryos used between stages
HH 8–10. Melanoma cells are placed into the neural tube at the
www.frontiersin.org February 2015 | Volume 5 | Article 36 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Jayachandran et al. Chicken embryo melanoma model
FIGURE 2 |Transplanting melanoma cells into the embryonic chick
neural tube. (A) Melanoma cells are labeled with DiO and allowed to
grow as hanging drop culture. They form variable sized aggregates after
24 h. (B) Large clumps are dissected into similar sized small clusters
using dissection tools. (C) A pulled glass pipette is used to aspirate a
small cluster. (D) Melanoma cells are transplanted to the neural tube in
the trunk region of the embryo. (E) Schematic of the caudal trunk
region of an E2.5 embryo. The arrow is located in the posterior
neuropore, showing the entry for a cluster of melanoma cells (green),
which can then be pushed or injected into the neural tube so it lies just
caudal to the most caudal somites (S). (F) Eggs are then re-sealed with
transparent tape and allowed to incubate for 48 h. (G) Clusters of
DiO-positive melanoma cells can be seen in the trunk neural tube
immediately after injection when imaged using a fluorescence
stereomicroscope (arrow). The head of the embryo is to the right.
(H) Embryo is processed 2 days following injection. (I) DiO-positive
melanoma cells can be seen under a fluorescence stereomicroscope in
the trunk neural tube and in the surrounding tissue (arrow).
level of rhombomere 1–2 (HH 8) to rhombomere 4 (HH 10)
(Figures 1F,G).
21. Seal the window in the eggshell with transparent tape and
re-incubate eggs in the incubator at 38°C for 48 h to allow
melanoma cells to invade the host tissue (Figure 2F). Following
injection, fluorescently labeled cells can be seen in the lumen
of the trunk neural tube (Figure 2G).
Harvesting chick embryo for image processing:
22. After 2 days, select the surviving embryos and harvest the
embryos individually and place it in 1× DPBS in a petridish
(Figure 2H).
23. Under the fluorescence stereomicroscope, dissect out the
membranes covering the embryo using microscissors and
microforceps.
24. Place embryos dorsal side up with needles on a Sylgard
petridish. Locate the fluorescent labeled melanoma cells within
the embryo using the upright stereomicroscope (Figure 2I).
25. Whole mount pictures are captured of the embryo containing
fluorescently labeled melanoma cells.
26. Using microscissors dissect the region of interest and fix it in
4% paraformaldehyde for 1 h on a shaker.
27. Wash the tissue in 1× DPBS and embed the embryos in 30%
sucrose in DPBS overnight at 4°C.
28. Transfer the tissue into a cryomold filled with Tissue-Tek OCT
Compound. Using forceps, position the tissue so cross-sections
can be cut and remove air bubbles.
29. Freeze in liquid nitrogen. Section tissues at 20µm using a
cryostat. Sections can be frozen and stored prior to mounting.
30. Mount slides in fluorescent mounting media or counterstain
with antibodies to visualize proteins of interest. DiO does fade
over time; therefore, it is advisable to examine and image
sections shortly after processing and mounting. Melanoma
cells can also be detected using anti-human antibodies, such
as Abcam ab7856 mouse anti-HLA DR+DP+DQ (CR3/43),
used at 1:200 dilution with a fluorescent secondary anti-mouse
antibody.
RESULTS AND DISCUSSION
Typical results of motility of melanoma cells within the embry-
onic chicken are shown in Figure 3. DiO was used to mark the
melanoma cells; however, anti-human HLA antibody also iden-
tifies melanoma cells (Figure S1 in Supplementary Material). We
initially transplanted melanoma cells into both head and trunk
regions of the neural tube. Analysis of two cell lines (LM-MEL-3,
LM-MEL-8) showed that cells transplanted into the head region
migrated far less readily than cells transplanted into the trunk
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FIGURE 3 | Migration of melanoma cells from the neural tube.
Melanoma cells labeled with DiO are green. (A,B) Cross-sections of
cranial (A) and trunk (B) levels showing the extent of migration of
LM-MEL-3 cells at 4 days post-injection (DPI). Arrowheads indicate the
cells that migrated the greatest distance from the middle of the dorsal
neural tube. (A) LM-MEL-3 cells are located dorsal to the hindbrain.
(B) LM-MEL-3 cells migrate further in trunk regions at 4 DPI. (C,D) Dorsal
view of melanoma cells migrating from the neural tube at 2 DPI. White
dotted line indicates the midline of the neural tube. (C) LM-MEL-3.
(D) LM-MEL-8. (E) Schematic of a cross-section through the trunk region
of the neural tube during neural crest or melanoma cell migration.
Melanoma cells are injected into the lumen of the neural tube (NT) and
some remain in this position without migrating. Cells emerge from the
neural tube at the dorsal surface (top) into the staging area (SA). They then
migrate along one of two major pathways: the dorsolateral pathway under
the ectoderm (DL) or the ventral pathway (V). (F,G) Cross-sections of trunk
at 2 DPI showing the location of (F) LM-MEL-3 and (G) LM-MEL-8 cells.
Cells can be seen along dorsolateral (arrowheads) and ventral (arrows)
pathways. The SA is indicated with a yellow arrow in (G). (H) Melanocyte
cells are found in the roof of the neural tube (arrow) but very few migrate
outside the neural tube. NT, neural tube. Scale bar is 100µm. Open arrows
indicate speckles of DiO that have transferred to non-melanoma cells.
region. A comparison of the migration of LM-MEL-3 at 4 days
post-injection is shown for the cranial region (Figure 3A, n= 4)
and the trunk (Figure 3B, n= 3). A similar difference in migra-
tion between head and trunk regions is also seen using LM-MEL-8
(n= 5 for each of head and trunk), which is a cell line with an
epithelial-like phenotype and deemed to be non-invasive on the
basis of in vitro characterization.
Previous work using the chicken embryo to assess melanoma
migration has used cranial regions (11) and trunk (9). Kulesa et al.
found that at cranial levels, a highly aggressive melanoma cell line
C8161 migrated well, while a poorly aggressive cell line C8161
was less responsive (11). In our hands, both LM-MEL-3 (invasive
mesenchymal-like) and LM-MEL-8 (non-invasive epithelial-like)
cell lines showed poor migration at cranial levels and much greater
migration at trunk levels, indicating that there were significant
differences in the environmental signals between these regions.
During normal development, the majority of melanocytes arises
from trunk levels (18, 19), see Figure 3E. We concluded that
the trunk was a preferable region for analyzing the migration of
melanoma cells, but comparison of migratory ability between cells
transplanted at cranial compared to trunk levels could be very
informative.
During development, neural crest cells in the trunk migrate
along two main pathways, the ventral pathway, which gives rise to
neurons and glia in dorsal root and sympathetic ganglia, Schwann
cells along nerves, melanocytes and adrenal chromaffin cells, and
the dorsolateral pathway, which gives rise solely to melanocytes
(19, 32–34). We analyzed cross-sections of embryos containing
LM-MEL-3 and LM-MEL-8 cells to see if the cell lines followed
these pathways. Cells from both LM-MEL-3 and LM-MEL-8
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migrated from the trunk neural tube and could be seen out-
side the neural tube at 2 days post-injection by a dorsal view of
whole mount embryos (Figures 3C,D). These migrated along the
dorsolateral and ventral pathways (Figures 3F,G). We observed
numerous cells located dorsal to the neural tube, a region termed
the staging area, where neural crest cells are found prior to migra-
tion along a pathway (Figure 3E, yellow arrow, Figure 3G). Cells
were also observed along the dorsolateral pathway adjacent to the
ectoderm, along the ventral pathway in association with the dor-
sal root ganglia, and a small proportion of cells were observed
in between the ventral and dorsolateral pathways. Neural crest
cells are found at each of these locations (35). This finding is in
line with earlier studies that have demonstrated that melanoma
cells migrated along both dorsolateral and ventral routes (11, 13).
Melanoma cells from another epithelial-like melanoma cell line
LM-MEL-71 (Figure S2 in Supplementary Material) also showed
migration outside the neural tube, along the dorsolateral and
ventral pathways. EMT in melanoma often occurs with acquisi-
tion of motility and concomitant decrease in the expression of
E-cadherin and gain in the expression of N-cadherin (12, 36).
Culturing both epithelial- and mesenchymal-like melanoma cell
lines as hanging drops do not induce changes in the expression
of E-cadherin (epithelial marker) and N-cadherin (mesenchymal
marker) (Figure S3 in Supplementary Material).
We also transplanted normal human melanocytes into the
trunk region. A very small number of melanocytes migrated away
from the neural tube, but this proportion was far less than the
migration observed from melanoma transplantations. Some cells
were observed in the roof plate of the neural tube, while others
remained in the lumen of the neural tube (Figure 3H). Previous
studies have reported that melanocyte aggregates integrated into
the roof plate but did not migrate outside the neural tube (13).
The microenvironment of the neural tube of chick embryos
affects the behavior of melanoma cells and promotes their migra-
tion along neural crest migratory pathways. In addition to chick
embryos, zebrafish and mouse embryos have been used previously
to provide either a receptive or potentially normalizing microenvi-
ronment that alters the behavior of human melanoma cells. Some
factors active during gastrulation and early organogenesis within
these embryonic microenvironments change the gene expression
pattern of melanoma cells, limiting tumor formation, and enabling
migratory potential (11, 26, 37). Bailey et al. identified a num-
ber of genes associated with EMT and migration upregulated in
melanoma cells post exposure to the chick microenvironment
(22). These gene products are excellent candidates to send and
receive signals instructing and maintaining migratory potential in
melanoma cells. Furthermore, epithelial-to-mesenchymal transi-
tions are generally described as a process requiring external stimuli
for their initiation (38). The process of neural crest development
and the molecular mechanisms involved show similarity across
species. For example, members of the BMP and Wnt families are
involved in regulating neural crest induction and emigration in
multiple species (39).
In conclusion, this model represents an accessible and poten-
tially powerful system for examining the invasive behavior and
remarkable plasticity of metastatic melanoma cells in vivo. It is
proving helpful for identifying intrinsic and microenvironmental
regulators and drivers of cellular migration. This should prove
valuable for the identification and validation of molecules involved
in metastatic behavior as well as for the development of therapies
that target related pathways.
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